Latest news
Loading news…
Excellergy develops immunology-based therapies focused on treating allergic diseases through novel biologic drug candidates.
Excellergy on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Excellergy was acquired by Novartis in 2026 for $2B.
Total Funding
$70M
Funding Rounds
2
Last Funding
Acquisitions
0
Monthly Visits
Contacts
1
About Excellergy
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Palo Alto, California, United States
Excellergy Funding Rounds
2 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Investor Names | Funding Stage | Org Industries | Org Hq City | Org Hq Country | Org Description | Org Number Of Employees | Org Website | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1–2 of 2Show
Page 1 / 1
Excellergy Key People
VP of Discovery
Chief Executive Officer and President
Co-Founder
Co-Founder
Chief Scientific Officer and Co-Founder
Chief Medical Officer
1
professional contacts at Excellergy
Contact execs at Excellergy →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Excellergy
Loading news…
FAQs about Excellergy
People who checked this page also checked these
Browse the full Acquirezy directory.